Study sheds new light on how migraines may occur and why those who are susceptible to migraines see improvements in symptoms as they age.
Pregnant women with a history of migraines are at greater risk of both prenatal and postnatal complications. A new study found migraine sufferers are at increased risk of hyperlipidemia and gestational diabetes during pregnancy, and postnatal depression following the birth of their child.
Four coagulation measures were associated with migraine with aura. These hemostatic factors may have a causal role in migraine with aura.
Findings suggest developing HDAC6 inhibitors could be a novel new therapeutic avenue for the treatment of migraines.
People who use cannabis to help manage the pain associated with chronic migraine are six times more likely to suffer from rebound headaches, or medication overuse headaches, than those who do not use marijuana.
Migraine sufferers who embarked on two-and-a-half hours of moderate to vigorous exercise per week reported a significant decline in their migraine triggers, including stress, depression, and sleep problems.
Plumes of glutamate in the brain could explain the onset of migraines with auras, a new study reports.
A new small scale study reveals psilocybin appears to have a beneficial effect for chronic migraine sufferers.
Researchers identify genetic factors that protect from the chronification of migraines.
Familial hemiplegic migraine type 2 (FHM2) causes a malfunction of astrocytes in the cingulate cortex. Manipulating astrocytes in the cingulate cortex reversed the disfunction, preventing an increase in migraine-like symptoms in mice carrying the FHM2 defect.
Researchers report the hormone prolactin, more commonly associated with lactation in new mothers, may underlie why women are more vulnerable to developing functional pain syndromes than men.
Transcranial magnetic stimulation (TMS) shows promise in diminishing the effects of early dementia and proves a safe and effective method for treating acute migraine and PPA.
